Cargando…
Optimized dispersion of nanoparticles for biological in vitro and in vivo studies
BACKGROUND: The aim of this study was to establish and validate a practical method to disperse nanoparticles in physiological solutions for biological in vitro and in vivo studies. RESULTS: TiO(2 )(rutile) dispersions were prepared in distilled water, PBS, or RPMI 1640 cell culture medium. Different...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584664/ https://www.ncbi.nlm.nih.gov/pubmed/18990217 http://dx.doi.org/10.1186/1743-8977-5-14 |
_version_ | 1782160817346576384 |
---|---|
author | Bihari, Peter Vippola, Minnamari Schultes, Stephan Praetner, Marc Khandoga, Alexander G Reichel, Christoph A Coester, Conrad Tuomi, Timo Rehberg, Markus Krombach, Fritz |
author_facet | Bihari, Peter Vippola, Minnamari Schultes, Stephan Praetner, Marc Khandoga, Alexander G Reichel, Christoph A Coester, Conrad Tuomi, Timo Rehberg, Markus Krombach, Fritz |
author_sort | Bihari, Peter |
collection | PubMed |
description | BACKGROUND: The aim of this study was to establish and validate a practical method to disperse nanoparticles in physiological solutions for biological in vitro and in vivo studies. RESULTS: TiO(2 )(rutile) dispersions were prepared in distilled water, PBS, or RPMI 1640 cell culture medium. Different ultrasound energies, various dispersion stabilizers (human, bovine, and mouse serum albumin, Tween 80, and mouse serum), various concentrations of stabilizers, and different sequences of preparation steps were applied. The size distribution of dispersed nanoparticles was analyzed by dynamic light scattering and zeta potential was measured using phase analysis light scattering. Nanoparticle size was also verified by transmission electron microscopy. A specific ultrasound energy of 4.2 × 10(5 )kJ/m(3 )was sufficient to disaggregate TiO(2 )(rutile) nanoparticles, whereas higher energy input did not further improve size reduction. The optimal sequence was first to sonicate the nanoparticles in water, then to add dispersion stabilizers, and finally to add buffered salt solution to the dispersion. The formation of coarse TiO(2 )(rutile) agglomerates in PBS or RPMI was prevented by addition of 1.5 mg/ml of human, bovine or mouse serum albumin, or mouse serum. The required concentration of albumin to stabilize the nanoparticle dispersion depended on the concentration of the nanoparticles in the dispersion. TiO(2 )(rutile) particle dispersions at a concentration lower than 0.2 mg/ml could be stabilized by the addition of 1.5 mg/ml albumin. TiO(2 )(rutile) particle dispersions prepared by this method were stable for up to at least 1 week. This method was suitable for preparing dispersions without coarse agglomerates (average diameter < 290 nm) from nanosized TiO(2 )(rutile), ZnO, Ag, SiO(x), SWNT, MWNT, and diesel SRM2975 particulate matter. CONCLUSION: The optimized dispersion method presented here appears to be effective and practicable for preparing dispersions of nanoparticles in physiological solutions without creating coarse agglomerates. |
format | Text |
id | pubmed-2584664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25846642008-11-19 Optimized dispersion of nanoparticles for biological in vitro and in vivo studies Bihari, Peter Vippola, Minnamari Schultes, Stephan Praetner, Marc Khandoga, Alexander G Reichel, Christoph A Coester, Conrad Tuomi, Timo Rehberg, Markus Krombach, Fritz Part Fibre Toxicol Methodology BACKGROUND: The aim of this study was to establish and validate a practical method to disperse nanoparticles in physiological solutions for biological in vitro and in vivo studies. RESULTS: TiO(2 )(rutile) dispersions were prepared in distilled water, PBS, or RPMI 1640 cell culture medium. Different ultrasound energies, various dispersion stabilizers (human, bovine, and mouse serum albumin, Tween 80, and mouse serum), various concentrations of stabilizers, and different sequences of preparation steps were applied. The size distribution of dispersed nanoparticles was analyzed by dynamic light scattering and zeta potential was measured using phase analysis light scattering. Nanoparticle size was also verified by transmission electron microscopy. A specific ultrasound energy of 4.2 × 10(5 )kJ/m(3 )was sufficient to disaggregate TiO(2 )(rutile) nanoparticles, whereas higher energy input did not further improve size reduction. The optimal sequence was first to sonicate the nanoparticles in water, then to add dispersion stabilizers, and finally to add buffered salt solution to the dispersion. The formation of coarse TiO(2 )(rutile) agglomerates in PBS or RPMI was prevented by addition of 1.5 mg/ml of human, bovine or mouse serum albumin, or mouse serum. The required concentration of albumin to stabilize the nanoparticle dispersion depended on the concentration of the nanoparticles in the dispersion. TiO(2 )(rutile) particle dispersions at a concentration lower than 0.2 mg/ml could be stabilized by the addition of 1.5 mg/ml albumin. TiO(2 )(rutile) particle dispersions prepared by this method were stable for up to at least 1 week. This method was suitable for preparing dispersions without coarse agglomerates (average diameter < 290 nm) from nanosized TiO(2 )(rutile), ZnO, Ag, SiO(x), SWNT, MWNT, and diesel SRM2975 particulate matter. CONCLUSION: The optimized dispersion method presented here appears to be effective and practicable for preparing dispersions of nanoparticles in physiological solutions without creating coarse agglomerates. BioMed Central 2008-11-06 /pmc/articles/PMC2584664/ /pubmed/18990217 http://dx.doi.org/10.1186/1743-8977-5-14 Text en Copyright © 2008 Bihari et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Bihari, Peter Vippola, Minnamari Schultes, Stephan Praetner, Marc Khandoga, Alexander G Reichel, Christoph A Coester, Conrad Tuomi, Timo Rehberg, Markus Krombach, Fritz Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title | Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title_full | Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title_fullStr | Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title_full_unstemmed | Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title_short | Optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
title_sort | optimized dispersion of nanoparticles for biological in vitro and in vivo studies |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584664/ https://www.ncbi.nlm.nih.gov/pubmed/18990217 http://dx.doi.org/10.1186/1743-8977-5-14 |
work_keys_str_mv | AT biharipeter optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT vippolaminnamari optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT schultesstephan optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT praetnermarc optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT khandogaalexanderg optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT reichelchristopha optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT coesterconrad optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT tuomitimo optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT rehbergmarkus optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies AT krombachfritz optimizeddispersionofnanoparticlesforbiologicalinvitroandinvivostudies |